(Q34099017)

31 July 2017

1 reference

title

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders (English)

1 reference

31 July 2017

0 references

0 references

De Petrocellis L

1 reference

31 July 2017

Melck D

series ordinal

1 reference

31 July 2017

Bisogno T

series ordinal

1 reference

31 July 2017

Di Marzo V

series ordinal

1 reference

31 July 2017

language of work or name

1 reference

1 November 2000

1 reference

Chemistry and Physics of Lipids

31 July 2017

published in

1 reference

31 July 2017

volume

108

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

191-209

1 reference

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Clinical management of anorexia and cachexia in patients with advanced cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

7 January 2021

Marijuana as a medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Control of pain initiation by endogenous cannabinoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Chemical characterization of a family of brain lipids that induce sleep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Interactions between synthetic vanilloids and the endogenous cannabinoid system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Menstrual cycle and appetite control: implications for weight regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Expression of functional trk protooncogene in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Cannabinoid CB1 Receptor Expression in Rat Spinal Cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Cannabinoid transmission and reward-related events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Neurotrophic factors in prostate and prostatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Cancer cachexia and cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Therapeutic use of cannabis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Structure-activity relationships of anandamide, an endogenous cannabinoid ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

cis-9,10-octadecenoamide, an endogenous sleep-inducing CNS compound, inhibits lymphocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Anandamide hydrolysis by human cells in culture and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Anandamide activates human platelets through a pathway independent of the arachidonate cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Pharmacological and biochemical interactions between opioids and cannabinoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Spinal cannabinoids are anti-allodynic in rats with persistent inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Anandamide may mediate sleep induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Antineoplastic Activity of Cannabinoids2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Cannabinoids induce incomplete maturation of cultured human leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Antihyperalgesic effects of spinal cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Δ9 -Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

N-acylated glycerophospholipids and their derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Cytoskeletal organization following cannabinoid treatment in undifferentiated and differentiated PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Effects of delta9-tetrahydrocannabinol in Lewis lung adenocarcinoma cells in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Cannabinoid enantiomer action on the cytoarchitecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Anandamide – the other side of the coin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900196-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-3084(00)00196-1

1 reference

31 July 2017

1 reference